The present invention is directed to a closure for a container and more specifically, to a closure for a medicament container, including removable overcap containing information related to the container and/or the contents of the container.
Liquid pharmaceutical products for application to a patient by a syringe are typically packaged in containers which are sealed with a stopper inserted into a neck of the container. A metallic cap seal is typically applied over the exterior opening of the neck to cover the end of the rubber stopper. The cap seal is secured to the neck by crimping the cap seal around a shoulder of the neck. The cap seal includes a small diameter hole at its center, facilitating the insertion of a needle of the syringe into the container. Limited amounts of information about the product may be imprinted on the cap seal.
A removable overcap is sometimes attached over the cap seal. The overcap may display limited amounts of product information such as the container's contents, brand name, dosage or strength of the medication in the container. The mechanism for attaching the overcap to the cap seal is expressly designed to be altered when the overcap removed from the cap seal, thus preventing replacement of the overcap on the cap seal. Consequently, the absence of the overcap on a container is a positive indication that access to the medicament or tampering of the container has been attempted. Such an overcap is described in U.S. Pat. No. 5,377,853.
The process of preparing containers of medicaments for shipment to a distributor typically includes steps of: (1) sterilizing an empty container, (2) filling the container with a medicament, (3) placing the rubber stopper in the neck of the container, (4) attaching the overcap to the cap seal, (5) sealing the end of the container with the cap seal/overcap assembly, (6) sterilizing the sealed container and (7) labeling the container with the contents of the container and other information related to the manufacturing history.
Particularly in the case of containers holding medicaments, it is of the utmost importance that the information on the labeling of each container correspond to the actual contents of the container and include such information that allows for traceability of the contents to the history of manufacture. Thus, information should ideally be associated with each filled container from near the moment that the container is filled.
Presently, however, it is not possible to include with each container at the time of filling, all of the required information on the container contents and on manufacturing the container contents, since labeling applied to the container at the time of filling would not survive the autoclaving step following filling, and there is insufficient room on the cap seal and/or on the overcap to include all of the required information. Further, the destination for each filled container is not known at the time the container is filled. Since the minimum information to be applied to a label is generally prescribed by law, and such laws vary from country to country, the labeling of containers can not be done until the destination of a particular lot of containers is determined. Such determination may not be made until after a specific lot of the containers has been shelved for a period of time. In order to reliably determine the contents of the containers in a lot that has been shelved, samples from each lot are generally taken from the shelved lot and the contents of the samples determined analytically prior to labeling. Such a procedure is time consuming and expensive.
A further problem associated with labeling of the containers is one of counterfeiting. Such counterfeiting may utilize packaging and labeling identical to legitimate articles such that even an experienced end user pharmacist or medical practitioner is unable distinguish the counterfeit article from the legitimate article.
Accordingly, there is a need for a method of tagging a container of medicament with information which provides: (1) a high level of confidence that the labeling on a container reflects the actual contents of the container, and (2) a high level of confidence that the container was filled by the manufacturer identified on the label. Preferably, the method of tagging would allow for the tagging to be applied substantially concurrently with the filling of the container with medicament such that sampling of the containers in a shelved lot would be unnecessary. Preferably, the method of tagging would also provide for storing information related to not only the container contents, but also information related to packaging and distribution of the individual containers.
Briefly stated, the present invention provides a closure for a container comprising a cap seal, and an overcap removably fastened to the cap seal, where the overcap includes a decorated film fused into a top surface.
In another aspect of the invention, the present invention provides an overcap for a container comprising a button-like member having a generally flat top surface and a decorated film fused into the top surface where the decorated film includes at least one image on a top side of the decorated film.
A further aspect of the invention includes a method of fabricating an overcap for a container comprising the steps of: forming a plurality of arrangements of at least one image on a top side of a substrate; attaching a plurality of memory devices on a bottom side of the substrate such that the plurality of arrangements and the plurality of memory devices are aligned; removing each one of the aligned arrangements and the memory devices from the substrate to form a plurality of decorated films; forming a plurality overcaps by inserting each of the plurality of decorated films into a mold with a top side of the decorated film adjacent to a wall of the mold; and injecting a polymeric material into the mold to form the overcap, wherein the decorated film is fused into a top surface of the overcap.
One additional aspect of the invention includes a method of establishing traceability of the contents of a medicament container, the method comprising the steps of: storing in a memory device an unalterable character string, the character string being uniquely associated with the memory device; and attaching the memory device to the container substantially concurrently with filling the container with the contents, wherein the filled container is thereafter exposed to sterilization, and wherein the memory device remains fully functional after the container is exposed to sterilization.
The foregoing summary, as well as the following detailed description of the invention, will be better understood when read in conjunction with the appended drawings. For the purpose of illustrating the invention, there are shown in the drawings embodiments which are presently preferred. It should be understood, however, that the invention is not limited to the precise arrangements and instrumentalities shown.
In the drawings:
Referring to the drawings, wherein like numerals are used to indicate like elements throughout the several figures and the use of the indefinite article “a” may indicate a quantity of one, or more than one of an element, there is shown in
The closure 10 comprises a cap seal 11 having a removably attached overcap 17. The cap seal 11 has an outer dependent skirt 42 for attachment to the container 12. A recessed lip 44 is formed on an inner terminal edge of a shoulder portion 46 of the cap seal 11. Preferably, an annular center section 48 having a centrally located hole 30, is attached to the recessed lip 44 by a plurality of spaced apart bridges 50 (
The overcap 17, (
Preferably, the overcap 17 incorporates a decorated film 16 (
In the preferred embodiment, the decorated film 16 is fabricated from a substrate 34. Preferably, the substrate 34 is a printable sheet of not greater than ten mils thickness, of a type that can survive a tortuous injection molding environment, which is un-moldable with a wide variety of thermoplastic and thermosetting materials and which can survive autoclaving when fused into the overcap 17. One such type of material is a silica filled micro-porous sheet material. Preferably, the substrate 34 is PPG Industries MIST ® ten mil thick material as described in the '634 patent. However, other precipitated silica filled micro-porous sheet materials may be used.
In the preferred embodiment, the decorated films 16 are formed by printing a plurality of arrangements 40 of one or more images 18 on the top side 24 of the substrate 34 (
Preferably, each one of the decorated films 16 is formed by removing each of the aligned arrangements 40 and its corresponding memory device 28 from the substrate 34 by a standard punching process. Preferably, each decorated film 16 is then inserted into a mold with the top side 24 of the decorated film 16 being adjacent to a wall of the mold. A polymeric material is then injected into the mold to form the overcap 17. Consequently, by virtue of the decorated film 16 being completely encased within (i.e. fused) the polymeric material of the overcap 17, the decorated film 16 is able to maintain legibility of the images 18 after being exposed to autoclaving, radiation such as gamma radiation or e-beam radiation, ethylene oxide gas or deep freezing. In one embodiment, the decorated film 16 is held against the wall of the mold by an electrostatic charge during the process of injecting the polymeric material into the mold.
The memory device 28 may be any type of device which is capable of permanently storing data, which may be wirelessly read and which is capable of full functionality after being exposed to autoclaving or deep freezing when integrated into the closure 10. Such devices may include, for example, magnetostrictive, magnetic, and passive resonant tags. In the preferred embodiment the memory device 28 is a radio frequency identification device (RFID) integrated circuit 28 and an associated antenna 26 (
In the preferred embodiment, the RFID integrated circuit 28 comprises 96 bits of memory, a portion of which is read-only memory. While it is preferred that the RFID include 96 bits of memory, the RFID could include as much as 3000 or more bits of memory. Preferably, the read-only portion of each RFID 28 is utilized for storing a character string unique to each RFID integrated circuit 28 (i.e. each overcap 17). The unique character string can not be changed by ordinary means. Consequently, when the overcap 17 is attached to the container 12, a unique serial becomes associated with the container 12. Additional information may be included in those portions of the memory which is not used for storing the unique character string. The additional information may be added and all the stored information may be wirelessly read either prior to or after molding the overcap 17 and at locations along the package and the product supply chain. Information stored in the RFID 28 may include but is not limited to: a custom serial number, a covert or forensic identifier, a specific package number, a manufacturing date, a manufacturing location, a product code, a customer code, a product fill date, a product expiration date, a manufacturing/filling location, a ship to location, a verify receipt, a verify dispensing date, a verify customer, a verify dose compliance and a verify product integrity. The information may be directly interpretable by the interrogating device or may be linkable to a database for interpretation.
Preferably, the images 18 in each one of the arrangement of images 40 are formed in layers, one over the other. However, each arrangement of the images 40 may be formed of images 18 in a single layer or may be a combination of layered and side-by-side images 18. The images 18 may be formed using lithography or similar processes such as screen printing, flexography, gravure, high resolution ink-jet printing and color or monochrome laser printing and may be of a variety of colors. Selected ones of the images 18 may also be formed of magnetic ink and be electrically readable.
An individual image 18 may be visible or invisible to the naked eye when viewed in light having a spectra which is substantially that of daylight. Where an image 18 is invisible to the naked eye in daylight spectra, the image may be made visible by illuminating the image 18 with radiation having a predetermined wavelength, such as ultra-violet radiation. Radiation of other wavelengths such as infra-red radiation or radiation having wavelengths in the radio and x-ray portions of the electromagnetic spectrum may also be used.
Preferably, the film 16 includes at least one image which is visible when illuminated with light having a spectra which is substantially that of daylight and at least one image which is invisible when illuminated with light having a spectra which is substantially that of daylight. An example of a decorated film 16 having a topmost layer of a visible image 18a and a second layer under the first layer having an invisible image 18b is shown in
An image 18, either visible or invisible, may comprise any type of image which may be printed, including a solid color which may be black, white or transparent, textual, graphical, photographic and biometric images. In particular, photographic or biometric types of images such as landscapes, fingerprints, iris scans etc., having a large amount of near random detail which is difficult to duplicate, can be printed on the decorated film 16 to create covert information for anti-counterfeiting or other purposes.
The overcap 17 is particularly suited for providing a high level of confidence that the labeling on a container 12 reflects the actual contents of the container 12, and that the container 12 was filled by the manufacturer identified on the label on the container 12 by establishing traceability of the contents of the container 12 by: storing in a memory device 28 an unalterable character string, where the character string is uniquely associated with the memory device 28, filling the 12, and attaching the memory device 28 to the container 12 substantially concurrently with filling the 12. Thus by attaching the memory device 18 with a unique character string and other information to the container 12 in the same time frame that the container 12 is filled, the likelihood is minimized of improperly recording in the memory device 18 the contents of the container 12 and the origin of the contents. Further, by reading the character string and/or other data from the memory device 28 and the indicia 18 from the overcap 17, a label may be prepared at the time of determining the ultimate destination of the container 12, without having to determine the contents of the container 12 analytically.
Containers which have been closed with the closure 10 may be exposed to sterilizing by autoclaving, e-beam radiation, gamma radiation, and ethylene oxide gas and to long term storage at freezing temperatures. In the preferred embodiment, the materials selected for the overcap 17 and the cap seal 11 are resistant to sterilizing the contents of the container 12 by autoclaving and gamma rays. Also, each one of the images 18 remains legible and the memory device remains fully functional after exposure to autoclaving at a temperature of 121 degrees Celsius for twenty minutes, and to exposure to temperatures of minus 80 degrees Celsius for periods of at least one month. Preferably, each one of the images 18 remains legible and the memory device remains fully functional after exposure to autoclaving at a temperature of 121 degrees Celsius for at least sixty minutes. Additionally, the images 18 remain legible when exposed to the sterilizing levels of gamma radiation and e-beam radiation. Such sterilizing levels are typically in the range of about 25 kgray.
As would be understood by those skilled in the art, the present invention is adapted to storing information which provides: (1) a high level of confidence that a label on a container 12 reflects the actual contents of the container 12, and (2) a high level of confidence that the container 12 was filled by the manufacturer identified on the label. The method of tagging the container 12 allows for the tagging to be applied substantially concurrently with the filling of the container 12 such that sampling of the containers 12 in a shelved lot is unnecessary for authenticating the contents. The claimed overcap also provides for storing information related to not only the container 12 contents, but also information related to packaging and distribution of the individual containers. 12 Also, selected information is concealed from a casual observer and may be made difficult to replicate, thus providing a measure of protection from counterfeiting.
It will be appreciated by those skilled in the art that changes could be made to the embodiments described above without departing from the broad inventive concept thereof. It is understood, therefore, that this invention is not limited to the particular embodiments disclosed, but it is intended to cover modifications within the spirit and scope of the present invention as defined by the appended claims.
This application is a Non-Provisional of Provisional Application No. 60/616,809, entitled “In-Mold Decorated Flip-Off Button”, filed Oct. 7, 2004, the contents of which are incorporated herein by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
3589280 | Wilde | Jun 1971 | A |
3628271 | Carrell et al. | Dec 1971 | A |
3899295 | Halpern | Aug 1975 | A |
4449042 | Hampson et al. | May 1984 | A |
4493989 | Hampson et al. | Jan 1985 | A |
5018632 | Schmidt | May 1991 | A |
5152413 | Conrad | Oct 1992 | A |
5255819 | Peckels | Oct 1993 | A |
5270717 | Schuermann | Dec 1993 | A |
5318197 | Martindale et al. | Jun 1994 | A |
5374930 | Schuermann | Dec 1994 | A |
5377853 | Papciak | Jan 1995 | A |
5379916 | Martindale et al. | Jan 1995 | A |
5448242 | Sharpe et al. | Sep 1995 | A |
5451958 | Schuermann | Sep 1995 | A |
5479171 | Schuermann | Dec 1995 | A |
5500651 | Schuermann | Mar 1996 | A |
5531344 | Winner | Jul 1996 | A |
5541604 | Meier | Jul 1996 | A |
5543798 | Schuermann | Aug 1996 | A |
5565846 | Geiszler et al. | Oct 1996 | A |
5594448 | d'Hont | Jan 1997 | A |
5602919 | Hurta et al. | Feb 1997 | A |
5603430 | Loehrke et al. | Feb 1997 | A |
5619207 | d'Hont | Apr 1997 | A |
5621411 | Hagl et al. | Apr 1997 | A |
5629981 | Nerlikar | May 1997 | A |
5708419 | Isaacson et al. | Jan 1998 | A |
5745036 | Clare | Apr 1998 | A |
5852590 | de la Huerga | Dec 1998 | A |
5883582 | Bowers et al. | Mar 1999 | A |
5929801 | Aslanidis et al. | Jul 1999 | A |
5955950 | Gallagher, III et al. | Sep 1999 | A |
5955969 | D'Hont | Sep 1999 | A |
5957313 | Bouan | Sep 1999 | A |
5959531 | Gallagher, III et al. | Sep 1999 | A |
5963134 | Bowers et al. | Oct 1999 | A |
5970148 | Meier | Oct 1999 | A |
6025780 | Bowers et al. | Feb 2000 | A |
6036055 | Mogadam et al. | Mar 2000 | A |
6040565 | Akerlind | Mar 2000 | A |
6072383 | Gallagher, III et al. | Jun 2000 | A |
6166706 | Gallagher, III et al. | Dec 2000 | A |
6195006 | Bowers et al. | Feb 2001 | B1 |
6208235 | Trontelj | Mar 2001 | B1 |
6226619 | Halperin et al. | May 2001 | B1 |
6259654 | de la Huerga | Jul 2001 | B1 |
6259794 | Dobbins | Jul 2001 | B1 |
6271753 | Shukla | Aug 2001 | B1 |
6313747 | Imaichi et al. | Nov 2001 | B2 |
6325244 | Vincent et al. | Dec 2001 | B2 |
6354468 | Riek | Mar 2002 | B1 |
6380858 | Yarin et al. | Apr 2002 | B1 |
6416152 | Matsuzaki et al. | Jul 2002 | B1 |
6491217 | Catan | Dec 2002 | B2 |
6505780 | Yassin et al. | Jan 2003 | B1 |
6520544 | Mitchell et al. | Feb 2003 | B1 |
6527181 | Kleeberg et al. | Mar 2003 | B1 |
6529446 | de la Huerga | Mar 2003 | B1 |
6544634 | Abrams | Apr 2003 | B1 |
6574166 | Niemiec | Jun 2003 | B2 |
6604650 | Sagar | Aug 2003 | B2 |
6616047 | Catan | Sep 2003 | B2 |
6641052 | Baillod et al. | Nov 2003 | B2 |
6676014 | Catan | Jan 2004 | B2 |
6677917 | Van Heerden et al. | Jan 2004 | B2 |
6693539 | Bowers et al. | Feb 2004 | B2 |
6751730 | Walker et al. | Jun 2004 | B1 |
6758397 | Catan | Jul 2004 | B2 |
6779024 | DeLaHuerga | Aug 2004 | B2 |
6782601 | Smeyak et al. | Aug 2004 | B2 |
6793127 | Alsafadi et al. | Sep 2004 | B2 |
6859745 | Carr et al. | Feb 2005 | B2 |
6879876 | O'Dougherty et al. | Apr 2005 | B2 |
7098794 | Lindsay et al. | Aug 2006 | B2 |
7112356 | Nomula et al. | Sep 2006 | B2 |
7166154 | Barreto | Jan 2007 | B2 |
20010014377 | Babb et al. | Aug 2001 | A1 |
20010017817 | De La Huerga | Aug 2001 | A1 |
20010021356 | Konrad | Sep 2001 | A1 |
20010028308 | De La Huerga | Oct 2001 | A1 |
20020039909 | Rankin | Apr 2002 | A1 |
20020067270 | Yarin et al. | Jun 2002 | A1 |
20020076819 | Bowman et al. | Jun 2002 | A1 |
20020093427 | Roth et al. | Jul 2002 | A1 |
20020116996 | Malzahn | Aug 2002 | A1 |
20020147629 | Alsafadi et al. | Oct 2002 | A1 |
20020161652 | Paullin et al. | Oct 2002 | A1 |
20020169635 | Shillingburg | Nov 2002 | A1 |
20020188259 | Hickle et al. | Dec 2002 | A1 |
20020189667 | O'Dougherty et al. | Dec 2002 | A1 |
20030004608 | O'Dougherty et al. | Jan 2003 | A1 |
20030007421 | Niemiec et al. | Jan 2003 | A1 |
20030011476 | Godfrey | Jan 2003 | A1 |
20030020613 | Cosnard | Jan 2003 | A1 |
20030023974 | Dagtas et al. | Jan 2003 | A1 |
20030037872 | Duschek | Feb 2003 | A1 |
20030043039 | Salemi et al. | Mar 2003 | A1 |
20030047530 | Durbin | Mar 2003 | A1 |
20030055589 | Mogadam | Mar 2003 | A1 |
20030057276 | Appalucci et al. | Mar 2003 | A1 |
20030061706 | Smeyak et al. | Apr 2003 | A1 |
20030080901 | Piotrowski | May 2003 | A1 |
20030085267 | Piotrowski et al. | May 2003 | A1 |
20030086338 | Sastry et al. | May 2003 | A1 |
20030088496 | Piotrowski | May 2003 | A1 |
20030095253 | Chow | May 2003 | A1 |
20030099158 | De la Huerga | May 2003 | A1 |
20030105729 | Waxler | Jun 2003 | A1 |
20030120607 | Piotrowski | Jun 2003 | A1 |
20030129283 | Martinez Carballido | Jul 2003 | A1 |
20030136801 | Garcia et al. | Jul 2003 | A1 |
20030174046 | Abrams | Sep 2003 | A1 |
20030174554 | Dunstone et al. | Sep 2003 | A1 |
20030183226 | Brand et al. | Oct 2003 | A1 |
20030235027 | Smeyak et al. | Dec 2003 | A1 |
20040008123 | Carrender et al. | Jan 2004 | A1 |
20040021751 | Steinmetz et al. | Feb 2004 | A1 |
20040027180 | Usami | Feb 2004 | A1 |
20040100415 | Veitch et al. | May 2004 | A1 |
20040117062 | Bonney et al. | Jun 2004 | A1 |
20040133305 | Jean-Pierre | Jul 2004 | A1 |
20040152202 | Van der Maas et al. | Aug 2004 | A1 |
20040172160 | O'Dougherty et al. | Sep 2004 | A1 |
20040193446 | Mayer et al. | Sep 2004 | A1 |
Number | Date | Country | |
---|---|---|---|
20060092013 A1 | May 2006 | US |
Number | Date | Country | |
---|---|---|---|
60616809 | Oct 2004 | US |